Pages that link to "Q33379044"
Jump to navigation
Jump to search
The following pages link to Bortezomib (Velcadetrade mark) in the Treatment of Multiple Myeloma (Q33379044):
Displaying 50 items.
- Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma (Q24600346) (← links)
- Thrombotic microangiopathy associated with proteasome inhibitors (Q26785826) (← links)
- Proteasome function is required for platelet production (Q28244689) (← links)
- Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model (Q28820977) (← links)
- Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data. (Q30828090) (← links)
- Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone (Q33400871) (← links)
- Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes (Q33414742) (← links)
- Proteasome inhibitor associated thrombotic microangiopathy (Q33432949) (← links)
- Novel panel of protein biomarkers to predict response to bortezomib-containing induction regimens in multiple myeloma patients (Q33887173) (← links)
- Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications (Q34043821) (← links)
- Limiting the power of p53 through the ubiquitin proteasome pathway (Q34342940) (← links)
- CSNK1α1 mediates malignant plasma cell survival (Q34774056) (← links)
- Changes in the Proteasome Pool during Malignant Transformation of Mouse Liver Cells (Q38634320) (← links)
- Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms (Q36020893) (← links)
- Induction treatment of acute myeloid leukemia in an elderly patient with intramarrow injection/administration of cytarabine: first report of a case (Q36410505) (← links)
- A virtual approach to evaluate therapies for management of multiple myeloma induced bone disease (Q37185494) (← links)
- Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response (Q37261144) (← links)
- An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo (Q37320140) (← links)
- New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression (Q37340398) (← links)
- APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome (Q37377197) (← links)
- Inhibitory kappa B kinases as targets for pharmacological regulation (Q37907354) (← links)
- Peptide-based proteasome inhibitors in anticancer drug design. (Q38192572) (← links)
- The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration (Q38520167) (← links)
- Oxidative stress and proteasome inhibitors in multiple myeloma (Q38717135) (← links)
- Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma (Q38730889) (← links)
- Characterization of a new human plasma cell leukemia cell line UHKT-944. (Q38918719) (← links)
- Review and Literature Mining on Proteostasis Factors and Cancer. (Q38950514) (← links)
- Development of novel selective peptidomimetics containing a boronic acid moiety, targeting the 20S proteasome as anticancer agents (Q38988876) (← links)
- Tumor Lysis Syndrome in Multiple Myeloma: An Increasingly Recognized Risk-A Report of Seven Cases (Q39134211) (← links)
- Immunoglobulin G4-related disease: a rare disease with an unusual presentation (Q41784184) (← links)
- Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy (Q42376067) (← links)
- Somatic and autonomic small fiber neuropathy induced by bortezomib therapy: an immunofluorescence study. (Q42752912) (← links)
- Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure (Q45892519) (← links)
- Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer. (Q47140422) (← links)
- Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease (Q47548339) (← links)
- Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition (Q48312486) (← links)
- Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway (Q48522982) (← links)
- Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes (Q49192001) (← links)
- Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma (Q49358494) (← links)
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi. (Q52590685) (← links)
- The role of preoperative vascular embolization in surgery for metastatic spinal tumours. (Q53626684) (← links)
- Non-invasive imaging of disrupted protein homeostasis induced by proteasome inhibitor treatment using chemical exchange saturation transfer MRI (Q57286490) (← links)
- Formulation of benzoxaborole drugs in PLLA: from materials preparation to in vitro release kinetics and cellular assays (Q57450094) (← links)
- [Clinical characteristics and prognosis of 56 multiple myeloma patients over 70 years of age complicated with other systemic diseases] (Q58122374) (← links)
- Development of Novel Peptidomimetics Containing a Vinyl Sulfone Moiety as Proteasome Inhibitors (Q58862067) (← links)
- Targeting Metalloenzymes for Therapeutic Intervention (Q59830619) (← links)
- Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits (Q61813541) (← links)
- Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor (Q64056370) (← links)
- New Insights in Anti-Angiogenesis in Multiple Myeloma. (Q64929502) (← links)
- Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer. (Q64929541) (← links)